Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteins.

Oncotarget · 2017 · PMC5652724 · PMID 29100330

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

Furthermore, ROP-HPV-E7 was at least as effective as immunization with native HPV, with a strong trend towards enhanced survival (Figure 4C ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.